Name | GDC-0927 |
---|
Description | GDC-0927 (SRN-927) is a novel, potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist. |
---|---|
Related Catalog | |
Target |
Estrogen receptor[1] |
In Vivo | GDC-0927 is a novel, potent, non-steroidal, orally bioavailable, selective ER antagonist/ER degrader (SERD) that induces tumor regression in estrogen receptor (ER)+breast cancer (BC) patient-derived xenograft models[1]. |
References |
Molecular Formula | C28H28FNO4 |
---|---|
Molecular Weight | 461.52 |
Storage condition | 2-8℃ |